MUTATION STATUS AND IMMUNOHISTOCHEMICAL CORRELATION OF EGFR MUTATIONS IN GASTROINTESTINAL STROMAL TUMORS
Ozkayalar H1, Ergoren MC2,3,*, Tuncel G2,3, Kurt S4, Cevik E4, Ozemri Sag S4, Yilmaz Ozguven B5, Kabukcuoglu F5, Mocan G1,2, Temel ŞG4,6,7,*
*Corresponding Author: Associate Professor Mahmut C. Ergoren, Department of Medical Genetics, Faculty of Medicine, Near East University, Near East Boulevard, 99138 Nicosia, Northern Cyprus. Tel.: +90-392-444-0535. Fax: +90-392-223-6461. E-mail: mahmucerkez.ergoren@neu.edu.tr. And/or: Associate Professor Sehime G. Temel, Department of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Özlüce Görüjke Kampüsü, 16059 Nilüfer, Bursa, Turkey. Tel.: +90-224-295-0000. Fax: +90-224-295-0019. E-mail: sehime@uludag.edu.tr.
page: 67

MATERIALS AND METHODS

Study Design, Participants and Immunohistochemical Analysis. In this study, 40 patients’ samples (19 females, 21 males) who were diagnosed with GIST, were found to be positive with c-KIT immunohistochemistry staining (Clone YR145; Cell Marque Corporation, Rocklin, CA, USA) and DOG-1 (Clone K9; Leica Biosystems, Wetzlar, Germany) between January 2013 and June 2018, at the Pathology Department of Şişli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey. All 40 tumor samples were fixed in 10.0% formalin for 10 hours at room temperature. Then they were embedded in paraffin sections (4 μm thick) and mounted onto positively-charged glass slides. Immunostaining was performed with an automated immunostainer (Ventana Medical Systems, Inc., Tucson, AZ, USA) using the EGFR antibody (Clone: EGFR.113, dilution: 1/200, Novocastra Laboratories Ltd., Newcastle, Tyne and Wear, UK) at the Pathology Department of Near East University Hospital, Nicosia, Cyprus. The stained slides were evaluated semiquantitatively by two independent pathologists. The EGFR scoring system was referred from the study of Edris et al. [17] as 0: absence of any staining; 1: weak staining (diffuse or focal); 2: strong staining (diffuse or focal). Genetic Analysis. DNA was isolated from the tumor tissue embedded in paraffin blocks using QIAamp® DNA FFPE Tissue Kit (Cat.: 56404, Qiagen GmbH, Hilden, Germany) according to the manufacturer’s protocol. Then, Therascreen® EGFR Pyro Kit (Cat.: 971480, Qiagen GmbH) was used for sequence-based detection and quantitation of mutations in the exons 18 (codon 719), exon 19 (deletion), exon 20 (codons 768 and 790) and exon 21 (codons 858 and 861) of the EGFR gene, according to the manufacturer’s protocol, using 10 ng of genomic DNA extracted from the tumor tissue at the Department of Medical Genetics, Faculty of Medicine, Bursa Uludag University, Bursa, Turkey.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006